Global Regenerative Medicine Supply, Demand and Key Producers, 2024-2030

Description

The global Regenerative Medicine market size is expected to reach $ 111830 million by 2030, rising at a market growth of 18.4% CAGR during the forecast period (2024-2030).

Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.

North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.

In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.

This report studies the global Regenerative Medicine demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Regenerative Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Regenerative Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Regenerative Medicine total market, 2019-2030, (USD Million)
Global Regenerative Medicine total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Regenerative Medicine total market, key domestic companies and share, (USD Million)
Global Regenerative Medicine revenue by player and market share 2019-2024, (USD Million)
Global Regenerative Medicine total market by Type, CAGR, 2019-2030, (USD Million)
Global Regenerative Medicine total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Regenerative Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan(Acelity), MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics and Osiris Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Regenerative Medicine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Regenerative Medicine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Regenerative Medicine Market, Segmentation by Type
    Cell Therapy
    Tissue Engineering
    Biomaterial
    Other

Global Regenerative Medicine Market, Segmentation by Application
    Dermatology
    Cardiovascular
    CNS
    Orthopedic
    Others

Companies Profiled:
    J & J (DePuy Synthes)
    Medtronic
    Zimmer Biomet
    Stryker
    Allergan(Acelity)
    MiMedx Group
    Organogenesis
    Fujifilm Cellular Dynamics
    Osiris Therapeutics
    Vcanbio
    CCBC
    Cytori
    Celgene
    Vericel Corporation
    Guanhao Biotech
    Mesoblast
    AMAG Pharmaceuticals (CBR)
    ViaCord
    CordLife
    Integra LifeSciences
    Nuvasive
    Cook Biotech
    Japan Tissue Engineering

Key Questions Answered
1. How big is the global Regenerative Medicine market?
2. What is the demand of the global Regenerative Medicine market?
3. What is the year over year growth of the global Regenerative Medicine market?
4. What is the total value of the global Regenerative Medicine market?
5. Who are the major players in the global Regenerative Medicine market?

Table of Contents

1 Supply Summary
    1.1 Regenerative Medicine Introduction
    1.2 World Regenerative Medicine Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Regenerative Medicine Total Market by Region (by Headquarter Location)
        1.3.1 World Regenerative Medicine Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Regenerative Medicine Market Size (2019-2030)
        1.3.3 China Regenerative Medicine Market Size (2019-2030)
        1.3.4 Europe Regenerative Medicine Market Size (2019-2030)
        1.3.5 Japan Regenerative Medicine Market Size (2019-2030)
        1.3.6 South Korea Regenerative Medicine Market Size (2019-2030)
        1.3.7 ASEAN Regenerative Medicine Market Size (2019-2030)
        1.3.8 India Regenerative Medicine Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Regenerative Medicine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Regenerative Medicine Major Market Trends

2 Demand Summary
    2.1 World Regenerative Medicine Consumption Value (2019-2030)
    2.2 World Regenerative Medicine Consumption Value by Region
        2.2.1 World Regenerative Medicine Consumption Value by Region (2019-2024)
        2.2.2 World Regenerative Medicine Consumption Value Forecast by Region (2025-2030)
    2.3 United States Regenerative Medicine Consumption Value (2019-2030)
    2.4 China Regenerative Medicine Consumption Value (2019-2030)
    2.5 Europe Regenerative Medicine Consumption Value (2019-2030)
    2.6 Japan Regenerative Medicine Consumption Value (2019-2030)
    2.7 South Korea Regenerative Medicine Consumption Value (2019-2030)
    2.8 ASEAN Regenerative Medicine Consumption Value (2019-2030)
    2.9 India Regenerative Medicine Consumption Value (2019-2030)

3 World Regenerative Medicine Companies Competitive Analysis
    3.1 World Regenerative Medicine Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Regenerative Medicine Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Regenerative Medicine in 2023
        3.2.3 Global Concentration Ratios (CR8) for Regenerative Medicine in 2023
    3.3 Regenerative Medicine Company Evaluation Quadrant
    3.4 Regenerative Medicine Market: Overall Company Footprint Analysis
        3.4.1 Regenerative Medicine Market: Region Footprint
        3.4.2 Regenerative Medicine Market: Company Product Type Footprint
        3.4.3 Regenerative Medicine Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Regenerative Medicine Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Regenerative Medicine Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Regenerative Medicine Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Regenerative Medicine Consumption Value Comparison
        4.2.1 United States VS China: Regenerative Medicine Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Regenerative Medicine Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Regenerative Medicine Companies and Market Share, 2019-2024
        4.3.1 United States Based Regenerative Medicine Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Regenerative Medicine Revenue, (2019-2024)
    4.4 China Based Companies Regenerative Medicine Revenue and Market Share, 2019-2024
        4.4.1 China Based Regenerative Medicine Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Regenerative Medicine Revenue, (2019-2024)
    4.5 Rest of World Based Regenerative Medicine Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Regenerative Medicine Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Regenerative Medicine Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Regenerative Medicine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Cell Therapy
        5.2.2 Tissue Engineering
        5.2.3 Biomaterial
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Regenerative Medicine Market Size by Type (2019-2024)
        5.3.2 World Regenerative Medicine Market Size by Type (2025-2030)
        5.3.3 World Regenerative Medicine Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Regenerative Medicine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Dermatology
        6.2.2 Cardiovascular
        6.2.3 CNS
        6.2.4 Orthopedic
        6.2.5 Orthopedic
    6.3 Market Segment by Application
        6.3.1 World Regenerative Medicine Market Size by Application (2019-2024)
        6.3.2 World Regenerative Medicine Market Size by Application (2025-2030)
        6.3.3 World Regenerative Medicine Market Size by Application (2019-2030)

7 Company Profiles
    7.1 J & J (DePuy Synthes)
        7.1.1 J & J (DePuy Synthes) Details
        7.1.2 J & J (DePuy Synthes) Major Business
        7.1.3 J & J (DePuy Synthes) Regenerative Medicine Product and Services
        7.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 J & J (DePuy Synthes) Recent Developments/Updates
        7.1.6 J & J (DePuy Synthes) Competitive Strengths & Weaknesses
    7.2 Medtronic
        7.2.1 Medtronic Details
        7.2.2 Medtronic Major Business
        7.2.3 Medtronic Regenerative Medicine Product and Services
        7.2.4 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Medtronic Recent Developments/Updates
        7.2.6 Medtronic Competitive Strengths & Weaknesses
    7.3 Zimmer Biomet
        7.3.1 Zimmer Biomet Details
        7.3.2 Zimmer Biomet Major Business
        7.3.3 Zimmer Biomet Regenerative Medicine Product and Services
        7.3.4 Zimmer Biomet Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Zimmer Biomet Recent Developments/Updates
        7.3.6 Zimmer Biomet Competitive Strengths & Weaknesses
    7.4 Stryker
        7.4.1 Stryker Details
        7.4.2 Stryker Major Business
        7.4.3 Stryker Regenerative Medicine Product and Services
        7.4.4 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Stryker Recent Developments/Updates
        7.4.6 Stryker Competitive Strengths & Weaknesses
    7.5 Allergan(Acelity)
        7.5.1 Allergan(Acelity) Details
        7.5.2 Allergan(Acelity) Major Business
        7.5.3 Allergan(Acelity) Regenerative Medicine Product and Services
        7.5.4 Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Allergan(Acelity) Recent Developments/Updates
        7.5.6 Allergan(Acelity) Competitive Strengths & Weaknesses
    7.6 MiMedx Group
        7.6.1 MiMedx Group Details
        7.6.2 MiMedx Group Major Business
        7.6.3 MiMedx Group Regenerative Medicine Product and Services
        7.6.4 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 MiMedx Group Recent Developments/Updates
        7.6.6 MiMedx Group Competitive Strengths & Weaknesses
    7.7 Organogenesis
        7.7.1 Organogenesis Details
        7.7.2 Organogenesis Major Business
        7.7.3 Organogenesis Regenerative Medicine Product and Services
        7.7.4 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Organogenesis Recent Developments/Updates
        7.7.6 Organogenesis Competitive Strengths & Weaknesses
    7.8 Fujifilm Cellular Dynamics
        7.8.1 Fujifilm Cellular Dynamics Details
        7.8.2 Fujifilm Cellular Dynamics Major Business
        7.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Product and Services
        7.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Fujifilm Cellular Dynamics Recent Developments/Updates
        7.8.6 Fujifilm Cellular Dynamics Competitive Strengths & Weaknesses
    7.9 Osiris Therapeutics
        7.9.1 Osiris Therapeutics Details
        7.9.2 Osiris Therapeutics Major Business
        7.9.3 Osiris Therapeutics Regenerative Medicine Product and Services
        7.9.4 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Osiris Therapeutics Recent Developments/Updates
        7.9.6 Osiris Therapeutics Competitive Strengths & Weaknesses
    7.10 Vcanbio
        7.10.1 Vcanbio Details
        7.10.2 Vcanbio Major Business
        7.10.3 Vcanbio Regenerative Medicine Product and Services
        7.10.4 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Vcanbio Recent Developments/Updates
        7.10.6 Vcanbio Competitive Strengths & Weaknesses
    7.11 CCBC
        7.11.1 CCBC Details
        7.11.2 CCBC Major Business
        7.11.3 CCBC Regenerative Medicine Product and Services
        7.11.4 CCBC Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 CCBC Recent Developments/Updates
        7.11.6 CCBC Competitive Strengths & Weaknesses
    7.12 Cytori
        7.12.1 Cytori Details
        7.12.2 Cytori Major Business
        7.12.3 Cytori Regenerative Medicine Product and Services
        7.12.4 Cytori Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Cytori Recent Developments/Updates
        7.12.6 Cytori Competitive Strengths & Weaknesses
    7.13 Celgene
        7.13.1 Celgene Details
        7.13.2 Celgene Major Business
        7.13.3 Celgene Regenerative Medicine Product and Services
        7.13.4 Celgene Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Celgene Recent Developments/Updates
        7.13.6 Celgene Competitive Strengths & Weaknesses
    7.14 Vericel Corporation
        7.14.1 Vericel Corporation Details
        7.14.2 Vericel Corporation Major Business
        7.14.3 Vericel Corporation Regenerative Medicine Product and Services
        7.14.4 Vericel Corporation Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Vericel Corporation Recent Developments/Updates
        7.14.6 Vericel Corporation Competitive Strengths & Weaknesses
    7.15 Guanhao Biotech
        7.15.1 Guanhao Biotech Details
        7.15.2 Guanhao Biotech Major Business
        7.15.3 Guanhao Biotech Regenerative Medicine Product and Services
        7.15.4 Guanhao Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Guanhao Biotech Recent Developments/Updates
        7.15.6 Guanhao Biotech Competitive Strengths & Weaknesses
    7.16 Mesoblast
        7.16.1 Mesoblast Details
        7.16.2 Mesoblast Major Business
        7.16.3 Mesoblast Regenerative Medicine Product and Services
        7.16.4 Mesoblast Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Mesoblast Recent Developments/Updates
        7.16.6 Mesoblast Competitive Strengths & Weaknesses
    7.17 AMAG Pharmaceuticals (CBR)
        7.17.1 AMAG Pharmaceuticals (CBR) Details
        7.17.2 AMAG Pharmaceuticals (CBR) Major Business
        7.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Product and Services
        7.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 AMAG Pharmaceuticals (CBR) Recent Developments/Updates
        7.17.6 AMAG Pharmaceuticals (CBR) Competitive Strengths & Weaknesses
    7.18 ViaCord
        7.18.1 ViaCord Details
        7.18.2 ViaCord Major Business
        7.18.3 ViaCord Regenerative Medicine Product and Services
        7.18.4 ViaCord Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 ViaCord Recent Developments/Updates
        7.18.6 ViaCord Competitive Strengths & Weaknesses
    7.19 CordLife
        7.19.1 CordLife Details
        7.19.2 CordLife Major Business
        7.19.3 CordLife Regenerative Medicine Product and Services
        7.19.4 CordLife Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.19.5 CordLife Recent Developments/Updates
        7.19.6 CordLife Competitive Strengths & Weaknesses
    7.20 Integra LifeSciences
        7.20.1 Integra LifeSciences Details
        7.20.2 Integra LifeSciences Major Business
        7.20.3 Integra LifeSciences Regenerative Medicine Product and Services
        7.20.4 Integra LifeSciences Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.20.5 Integra LifeSciences Recent Developments/Updates
        7.20.6 Integra LifeSciences Competitive Strengths & Weaknesses
    7.21 Nuvasive
        7.21.1 Nuvasive Details
        7.21.2 Nuvasive Major Business
        7.21.3 Nuvasive Regenerative Medicine Product and Services
        7.21.4 Nuvasive Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.21.5 Nuvasive Recent Developments/Updates
        7.21.6 Nuvasive Competitive Strengths & Weaknesses
    7.22 Cook Biotech
        7.22.1 Cook Biotech Details
        7.22.2 Cook Biotech Major Business
        7.22.3 Cook Biotech Regenerative Medicine Product and Services
        7.22.4 Cook Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.22.5 Cook Biotech Recent Developments/Updates
        7.22.6 Cook Biotech Competitive Strengths & Weaknesses
    7.23 Japan Tissue Engineering
        7.23.1 Japan Tissue Engineering Details
        7.23.2 Japan Tissue Engineering Major Business
        7.23.3 Japan Tissue Engineering Regenerative Medicine Product and Services
        7.23.4 Japan Tissue Engineering Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024)
        7.23.5 Japan Tissue Engineering Recent Developments/Updates
        7.23.6 Japan Tissue Engineering Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Regenerative Medicine Industry Chain
    8.2 Regenerative Medicine Upstream Analysis
    8.3 Regenerative Medicine Midstream Analysis
    8.4 Regenerative Medicine Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Regenerative Medicine Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Regenerative Medicine Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Regenerative Medicine Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Regenerative Medicine Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Regenerative Medicine Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Regenerative Medicine Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Regenerative Medicine Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Regenerative Medicine Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Regenerative Medicine Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Regenerative Medicine Players in 2023
    Table 12. World Regenerative Medicine Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Regenerative Medicine Company Evaluation Quadrant
    Table 14. Head Office of Key Regenerative Medicine Player
    Table 15. Regenerative Medicine Market: Company Product Type Footprint
    Table 16. Regenerative Medicine Market: Company Product Application Footprint
    Table 17. Regenerative Medicine Mergers & Acquisitions Activity
    Table 18. United States VS China Regenerative Medicine Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Regenerative Medicine Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Regenerative Medicine Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Regenerative Medicine Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Regenerative Medicine Revenue Market Share (2019-2024)
    Table 23. China Based Regenerative Medicine Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Regenerative Medicine Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Regenerative Medicine Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Regenerative Medicine Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Regenerative Medicine Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Regenerative Medicine Revenue Market Share (2019-2024)
    Table 29. World Regenerative Medicine Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Regenerative Medicine Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Regenerative Medicine Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Regenerative Medicine Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Regenerative Medicine Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Regenerative Medicine Market Size by Application (2025-2030) & (USD Million)
    Table 35. J & J (DePuy Synthes) Basic Information, Area Served and Competitors
    Table 36. J & J (DePuy Synthes) Major Business
    Table 37. J & J (DePuy Synthes) Regenerative Medicine Product and Services
    Table 38. J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. J & J (DePuy Synthes) Recent Developments/Updates
    Table 40. J & J (DePuy Synthes) Competitive Strengths & Weaknesses
    Table 41. Medtronic Basic Information, Area Served and Competitors
    Table 42. Medtronic Major Business
    Table 43. Medtronic Regenerative Medicine Product and Services
    Table 44. Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Medtronic Recent Developments/Updates
    Table 46. Medtronic Competitive Strengths & Weaknesses
    Table 47. Zimmer Biomet Basic Information, Area Served and Competitors
    Table 48. Zimmer Biomet Major Business
    Table 49. Zimmer Biomet Regenerative Medicine Product and Services
    Table 50. Zimmer Biomet Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Zimmer Biomet Recent Developments/Updates
    Table 52. Zimmer Biomet Competitive Strengths & Weaknesses
    Table 53. Stryker Basic Information, Area Served and Competitors
    Table 54. Stryker Major Business
    Table 55. Stryker Regenerative Medicine Product and Services
    Table 56. Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Stryker Recent Developments/Updates
    Table 58. Stryker Competitive Strengths & Weaknesses
    Table 59. Allergan(Acelity) Basic Information, Area Served and Competitors
    Table 60. Allergan(Acelity) Major Business
    Table 61. Allergan(Acelity) Regenerative Medicine Product and Services
    Table 62. Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Allergan(Acelity) Recent Developments/Updates
    Table 64. Allergan(Acelity) Competitive Strengths & Weaknesses
    Table 65. MiMedx Group Basic Information, Area Served and Competitors
    Table 66. MiMedx Group Major Business
    Table 67. MiMedx Group Regenerative Medicine Product and Services
    Table 68. MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. MiMedx Group Recent Developments/Updates
    Table 70. MiMedx Group Competitive Strengths & Weaknesses
    Table 71. Organogenesis Basic Information, Area Served and Competitors
    Table 72. Organogenesis Major Business
    Table 73. Organogenesis Regenerative Medicine Product and Services
    Table 74. Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Organogenesis Recent Developments/Updates
    Table 76. Organogenesis Competitive Strengths & Weaknesses
    Table 77. Fujifilm Cellular Dynamics Basic Information, Area Served and Competitors
    Table 78. Fujifilm Cellular Dynamics Major Business
    Table 79. Fujifilm Cellular Dynamics Regenerative Medicine Product and Services
    Table 80. Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Fujifilm Cellular Dynamics Recent Developments/Updates
    Table 82. Fujifilm Cellular Dynamics Competitive Strengths & Weaknesses
    Table 83. Osiris Therapeutics Basic Information, Area Served and Competitors
    Table 84. Osiris Therapeutics Major Business
    Table 85. Osiris Therapeutics Regenerative Medicine Product and Services
    Table 86. Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Osiris Therapeutics Recent Developments/Updates
    Table 88. Osiris Therapeutics Competitive Strengths & Weaknesses
    Table 89. Vcanbio Basic Information, Area Served and Competitors
    Table 90. Vcanbio Major Business
    Table 91. Vcanbio Regenerative Medicine Product and Services
    Table 92. Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Vcanbio Recent Developments/Updates
    Table 94. Vcanbio Competitive Strengths & Weaknesses
    Table 95. CCBC Basic Information, Area Served and Competitors
    Table 96. CCBC Major Business
    Table 97. CCBC Regenerative Medicine Product and Services
    Table 98. CCBC Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. CCBC Recent Developments/Updates
    Table 100. CCBC Competitive Strengths & Weaknesses
    Table 101. Cytori Basic Information, Area Served and Competitors
    Table 102. Cytori Major Business
    Table 103. Cytori Regenerative Medicine Product and Services
    Table 104. Cytori Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Cytori Recent Developments/Updates
    Table 106. Cytori Competitive Strengths & Weaknesses
    Table 107. Celgene Basic Information, Area Served and Competitors
    Table 108. Celgene Major Business
    Table 109. Celgene Regenerative Medicine Product and Services
    Table 110. Celgene Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Celgene Recent Developments/Updates
    Table 112. Celgene Competitive Strengths & Weaknesses
    Table 113. Vericel Corporation Basic Information, Area Served and Competitors
    Table 114. Vericel Corporation Major Business
    Table 115. Vericel Corporation Regenerative Medicine Product and Services
    Table 116. Vericel Corporation Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Vericel Corporation Recent Developments/Updates
    Table 118. Vericel Corporation Competitive Strengths & Weaknesses
    Table 119. Guanhao Biotech Basic Information, Area Served and Competitors
    Table 120. Guanhao Biotech Major Business
    Table 121. Guanhao Biotech Regenerative Medicine Product and Services
    Table 122. Guanhao Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Guanhao Biotech Recent Developments/Updates
    Table 124. Guanhao Biotech Competitive Strengths & Weaknesses
    Table 125. Mesoblast Basic Information, Area Served and Competitors
    Table 126. Mesoblast Major Business
    Table 127. Mesoblast Regenerative Medicine Product and Services
    Table 128. Mesoblast Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. Mesoblast Recent Developments/Updates
    Table 130. Mesoblast Competitive Strengths & Weaknesses
    Table 131. AMAG Pharmaceuticals (CBR) Basic Information, Area Served and Competitors
    Table 132. AMAG Pharmaceuticals (CBR) Major Business
    Table 133. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product and Services
    Table 134. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 135. AMAG Pharmaceuticals (CBR) Recent Developments/Updates
    Table 136. AMAG Pharmaceuticals (CBR) Competitive Strengths & Weaknesses
    Table 137. ViaCord Basic Information, Area Served and Competitors
    Table 138. ViaCord Major Business
    Table 139. ViaCord Regenerative Medicine Product and Services
    Table 140. ViaCord Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 141. ViaCord Recent Developments/Updates
    Table 142. ViaCord Competitive Strengths & Weaknesses
    Table 143. CordLife Basic Information, Area Served and Competitors
    Table 144. CordLife Major Business
    Table 145. CordLife Regenerative Medicine Product and Services
    Table 146. CordLife Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 147. CordLife Recent Developments/Updates
    Table 148. CordLife Competitive Strengths & Weaknesses
    Table 149. Integra LifeSciences Basic Information, Area Served and Competitors
    Table 150. Integra LifeSciences Major Business
    Table 151. Integra LifeSciences Regenerative Medicine Product and Services
    Table 152. Integra LifeSciences Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 153. Integra LifeSciences Recent Developments/Updates
    Table 154. Integra LifeSciences Competitive Strengths & Weaknesses
    Table 155. Nuvasive Basic Information, Area Served and Competitors
    Table 156. Nuvasive Major Business
    Table 157. Nuvasive Regenerative Medicine Product and Services
    Table 158. Nuvasive Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 159. Nuvasive Recent Developments/Updates
    Table 160. Nuvasive Competitive Strengths & Weaknesses
    Table 161. Cook Biotech Basic Information, Area Served and Competitors
    Table 162. Cook Biotech Major Business
    Table 163. Cook Biotech Regenerative Medicine Product and Services
    Table 164. Cook Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 165. Cook Biotech Recent Developments/Updates
    Table 166. Japan Tissue Engineering Basic Information, Area Served and Competitors
    Table 167. Japan Tissue Engineering Major Business
    Table 168. Japan Tissue Engineering Regenerative Medicine Product and Services
    Table 169. Japan Tissue Engineering Regenerative Medicine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 170. Global Key Players of Regenerative Medicine Upstream (Raw Materials)
    Table 171. Regenerative Medicine Typical Customers
List of Figure
    Figure 1. Regenerative Medicine Picture
    Figure 2. World Regenerative Medicine Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Regenerative Medicine Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Regenerative Medicine Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Regenerative Medicine Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Regenerative Medicine Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Regenerative Medicine Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Regenerative Medicine Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Regenerative Medicine Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Regenerative Medicine Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Regenerative Medicine Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Regenerative Medicine Revenue (2019-2030) & (USD Million)
    Figure 13. Regenerative Medicine Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Regenerative Medicine Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Regenerative Medicine Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Regenerative Medicine by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Regenerative Medicine Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Regenerative Medicine Markets in 2023
    Figure 27. United States VS China: Regenerative Medicine Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Regenerative Medicine Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Regenerative Medicine Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Regenerative Medicine Market Size Market Share by Type in 2023
    Figure 31. Cell Therapy
    Figure 32. Tissue Engineering
    Figure 33. Biomaterial
    Figure 34. Other
    Figure 35. World Regenerative Medicine Market Size Market Share by Type (2019-2030)
    Figure 36. World Regenerative Medicine Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Regenerative Medicine Market Size Market Share by Application in 2023
    Figure 38. Dermatology
    Figure 39. Cardiovascular
    Figure 40. CNS
    Figure 41. Orthopedic
    Figure 42. Others
    Figure 43. Regenerative Medicine Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Companies Mentioned

J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering